BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2376330)

  • 1. Autoantibodies of systemic rheumatic diseases in the healthy elderly.
    Ruffatti A; Rossi L; Calligaro A; Del Ross T; Lagni M; Marson P; Todesco S
    Gerontology; 1990; 36(2):104-11. PubMed ID: 2376330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of anticardiolipin antibodies in a healthy elderly population and its association with antinuclear antibodies.
    Fields RA; Toubbeh H; Searles RP; Bankhurst AD
    J Rheumatol; 1989 May; 16(5):623-5. PubMed ID: 2787862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of anticardiolipin antibodies in the elderly British population.
    Chakravarty KK; Gray RE; Webley M; Byron MA; Wozniak J
    Postgrad Med J; 1991 Apr; 67(786):358-61. PubMed ID: 2068029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic tests in the diagnosis of rheumatic diseases. Part I.
    McDuffie FC; Bunch TW
    Bull Rheum Dis; 1976-1977; 27(5):900-5. PubMed ID: 65195
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-DFS70/LEDGF antibodies are more prevalent in healthy individuals compared to patients with systemic autoimmune rheumatic diseases.
    Mahler M; Parker T; Peebles CL; Andrade LE; Swart A; Carbone Y; Ferguson DJ; Villalta D; Bizzaro N; Hanly JG; Fritzler MJ
    J Rheumatol; 2012 Nov; 39(11):2104-10. PubMed ID: 22942262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of rheumatic diseases: tests and traps.
    Schmidt MC
    Hosp Pract (Off Ed); 1984 Sep; 19(9):82E-82G, 82K, 82O passim. PubMed ID: 6432827
    [No Abstract]   [Full Text] [Related]  

  • 7. [Significance of selected laboratory findings in rheumatic diseases. 2: The second step in diagnosis].
    Apostoloff E; Hiepe F; Mielke F
    Z Arztl Fortbild (Jena); 1987; 81(9):409-12. PubMed ID: 3498267
    [No Abstract]   [Full Text] [Related]  

  • 8. Autoantibodies and rheumatic disorders in a neurology inpatient population: a prospective study.
    Olsen ML; O'Connor S; Arnett FC; Rosenbaum D; Grotta JC; Warner NB
    Am J Med; 1991 Apr; 90(4):479-88. PubMed ID: 1901447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anticardiolipin antibodies in autoimmune rheumatic diseases].
    Ergüven S; Calgüner M; Gülmezoğlu E; Sungur C; Ozcebe OI
    Mikrobiyol Bul; 1989 Jan; 23(1):1-11. PubMed ID: 2696861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Incidence of seropositivity for rheumatoid factor in relation to age].
    Marcolongo R; Di Paolo N
    G Gerontol; 1972 Jun; 20(6):505-22. PubMed ID: 4114793
    [No Abstract]   [Full Text] [Related]  

  • 11. High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population.
    Manoussakis MN; Tzioufas AG; Silis MP; Pange PJ; Goudevenos J; Moutsopoulos HM
    Clin Exp Immunol; 1987 Sep; 69(3):557-65. PubMed ID: 3499270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of antinuclear antibodies in malignant diseases: association with rheumatic and connective tissue paraneoplastic syndromes.
    Solans-Laqué R; Pérez-Bocanegra C; Salud-Salvia A; Fonollosa-Plá V; Rodrigo MJ; Armadans L; Simeón-Aznar CP; Vilardell-Tarres M
    Lupus; 2004; 13(3):159-64. PubMed ID: 15119543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunologic diagnosis of rheumatic diseases].
    Müller W
    Ric Clin Lab; 1977; 7 Suppl 2():11-26. PubMed ID: 304237
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current status of immunological diagnosis in rheumatic diseases].
    Furcoi I
    Rev Med Chir Soc Med Nat Iasi; 1977; 81(1):139-40. PubMed ID: 68533
    [No Abstract]   [Full Text] [Related]  

  • 15. Screening test for rheumatic diseases: a combined enzyme immunoassay of rheumatoid factors and antibodies to DNA and extractable nuclear antigens.
    Kurki P; Gripenberg M; Partanen P; Helve T
    J Clin Pathol; 1987 Dec; 40(12):1475-80. PubMed ID: 3323254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [IgG type rheumatoid factor in inflammatory rheumatism].
    Simplicio F; Lapadula G; Carrozzo M
    Reumatismo; 1975; 27(1):244-50. PubMed ID: 1085967
    [No Abstract]   [Full Text] [Related]  

  • 17. [Our experience in the study of nuclear and antinuclear constituant antibodies in rheumatology].
    Kahn MF; Dryll A; de Seze S
    J Belge Rhumatol Med Phys; 1967; 22(4):217-30. PubMed ID: 4185873
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence and disease associations of certain autoantibodies in elderly patients.
    Juby AG; Davis P
    Clin Invest Med; 1998 Feb; 21(1):4-11. PubMed ID: 9512879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Problems of the immunological diagnosis in rheumatic diseases].
    Ivan A; Furcoi I
    Rev Med Chir Soc Med Nat Iasi; 1979; 83(3):512, 524. PubMed ID: 16296480
    [No Abstract]   [Full Text] [Related]  

  • 20. [Plasma beta 2 microglobulin in rheumatoid disease].
    Corvetta A; Ghirelli PA; Recchioni A; Sprovieri G
    G Clin Med; 1981 Jan; 62(1):13-22. PubMed ID: 6164593
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.